Individualized dosing of evinacumab is predicted to yield reductions in drug expenses

Rob ter Heine*, Gerard A. Rongen, Jeanine Roeters van Lennep, Joost H.W. Rutten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

38 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Individualized dosing of evinacumab is predicted to yield reductions in drug expenses'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science